secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001193125-26-045543
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics files updated corporate presentation; no specific new data disclosed in filing.
--------------------------------------------------------------------------------

- Company posted February 2026 investor presentation on its website.
- Presentation title: 'Accelerating the Development of Advanced Therapies for Cancer Patients'.
- No financial or clinical trial results were included in the 8-K filing.
- Investors should refer to the full presentation on the company's website for details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526045543/0001193125-26-045543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526045543/d47566d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-045543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer